Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
cancer cells from growing. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die. Combining biological therapy with chemotherapy may
kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of biological therapy combined with
temozolomide in treating patients who have metastatic melanoma.